$ULBI
ULTRALIFE CORP

2023 Q4 Form 10-Q Financial Statement

#000143774923029036 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $44.55M $39.49M
YoY Change 23.38% 18.82%
Cost Of Revenue $33.15M $29.71M
YoY Change 18.27% 12.05%
Gross Profit $11.40M $9.774M
YoY Change 41.1% 45.55%
Gross Profit Margin 25.59% 24.75%
Selling, General & Admin $5.901M $5.770M
YoY Change -4.95% 6.75%
% of Gross Profit 51.75% 59.03%
Research & Development $1.852M $1.869M
YoY Change 11.84% -1.42%
% of Gross Profit 16.24% 19.12%
Depreciation & Amortization $971.0K $760.0K
YoY Change -6.63% -6.75%
% of Gross Profit 8.52% 7.78%
Operating Expenses $7.753M $7.639M
YoY Change -1.41% 4.63%
Operating Profit $3.649M $2.135M
YoY Change 1581.57% -464.33%
Interest Expense -$566.0K -$590.0K
YoY Change 53.8% 116.91%
% of Operating Profit -15.51% -27.63%
Other Income/Expense, Net -$536.0K -$386.0K
YoY Change -10.22% -251.97%
Pretax Income $3.113M $1.749M
YoY Change -919.21% -626.81%
Income Tax $263.0K $446.0K
% Of Pretax Income 8.45% 25.5%
Net Earnings $2.873M $1.330M
YoY Change -1382.59% -656.49%
Net Earnings / Revenue 6.45% 3.37%
Basic Earnings Per Share $0.21
Diluted Earnings Per Share $0.17 $0.21
COMMON SHARES
Basic Shares Outstanding 16.34M 16.15M
Diluted Shares Outstanding 16.30M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.28M $9.200M
YoY Change 79.91% 82.14%
Cash & Equivalents $10.20M $9.223M
Short-Term Investments
Other Short-Term Assets $5.949M $6.500M
YoY Change 38.22% 4.15%
Inventory $42.22M $46.63M
Prepaid Expenses
Receivables $31.76M $27.19M
Other Receivables $0.00 $0.00
Total Short-Term Assets $90.20M $89.55M
YoY Change 14.2% 13.45%
LONG-TERM ASSETS
Property, Plant & Equipment $21.12M $21.17M
YoY Change -2.76% -3.34%
Goodwill $37.57M $37.36M
YoY Change 0.38% 0.79%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.28M $2.035M
YoY Change -0.69% 2.73%
Total Long-Term Assets $88.07M $86.56M
YoY Change -1.53% -2.75%
TOTAL ASSETS
Total Short-Term Assets $90.20M $89.55M
Total Long-Term Assets $88.07M $86.56M
Total Assets $178.3M $176.1M
YoY Change 5.85% 4.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.34M $13.47M
YoY Change -29.48% -14.89%
Accrued Expenses $10.39M $10.90M
YoY Change -4.11% 6.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $2.000M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $23.73M $26.39M
YoY Change -17.93% -6.04%
LONG-TERM LIABILITIES
Long-Term Debt $23.62M $24.11M
YoY Change 22.34% 15.49%
Other Long-Term Liabilities $3.781M $2.032M
YoY Change 100.37% 21.46%
Total Long-Term Liabilities $27.41M $26.14M
YoY Change 29.29% 15.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.73M $26.39M
Total Long-Term Liabilities $27.41M $26.14M
Total Liabilities $52.94M $54.35M
YoY Change 1.52% 3.28%
SHAREHOLDERS EQUITY
Retained Earnings -$40.75M -$43.63M
YoY Change -15.01% -8.59%
Common Stock $2.078M $2.075M
YoY Change 1.02% 0.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $21.49M
YoY Change 0.04%
Treasury Stock Shares
Shareholders Equity $125.3M $121.6M
YoY Change
Total Liabilities & Shareholders Equity $178.3M $176.1M
YoY Change 5.85% 4.86%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $2.873M $1.330M
YoY Change -1382.59% -656.49%
Depreciation, Depletion And Amortization $971.0K $760.0K
YoY Change -6.63% -6.75%
Cash From Operating Activities $2.429M -$890.0K
YoY Change -5.27% 108.43%
INVESTING ACTIVITIES
Capital Expenditures $1.002M $540.0K
YoY Change 254.06% -166.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.002M -$540.0K
YoY Change 254.06% -33.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -300.0K 2.430M
YoY Change -81.0% 86.49%
NET CHANGE
Cash From Operating Activities 2.429M -890.0K
Cash From Investing Activities -1.002M -540.0K
Cash From Financing Activities -300.0K 2.430M
Net Change In Cash 1.127M 1.000M
YoY Change 60.54% 1438.46%
FREE CASH FLOW
Cash From Operating Activities $2.429M -$890.0K
Capital Expenditures $1.002M $540.0K
Free Cash Flow $1.427M -$1.430M
YoY Change -37.44% -472.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
121758000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1869000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2135000 usd
CY2023Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
586000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2467000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20746546
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16311194
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2075000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188852000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43627000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4176000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
121640000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
118000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176109000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39488000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
115316000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119675000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1303000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
979000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
130000 usd
CY2023Q3 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
1000 usd
CY2023Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-330000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
121758000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
33234000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
114096000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000875657
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13470000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8449000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
26386000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24108000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1825000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2032000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
54351000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4435352
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21484000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
9774000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7639000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-386000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1749000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1303000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1330000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-330000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1691000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-426000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1930000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3898000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16238000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16133000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16172000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
65000
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16303000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16133000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16174000
us-gaap Profit Loss
ProfitLoss
4316000 usd
us-gaap Profit Loss
ProfitLoss
105000 usd
us-gaap Depreciation
Depreciation
2282000 usd
us-gaap Depreciation
Depreciation
2450000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
663000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
969000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
25000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
424000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
552000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1245000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
683000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-565000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7433000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5626000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8714000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1972000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1004000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2448000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
9906000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-503000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3827000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1547000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1396000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1547000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1396000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6250000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3350000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1500000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1333000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1041000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
116000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
25000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-3189000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
115316000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116403000 usd
us-gaap Profit Loss
ProfitLoss
4316000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1041000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
421000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
3000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-426000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
121758000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117067000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-242000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
176000 usd
CY2022Q3 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
3000 usd
CY2022Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-1691000 usd
CY2023Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
677029
CY2023Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
2500
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
65275
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
22165
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
2500
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2441
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
128665
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22203
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9223000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5634000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
78000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
79000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9301000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5713000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
31516000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29200000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4342000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2757000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10776000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9235000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
46634000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
41192000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
86709000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
92660000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
65543000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70944000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21166000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21716000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
760000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
815000 usd
us-gaap Depreciation
Depreciation
2282000 usd
us-gaap Depreciation
Depreciation
2450000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
37428000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-71000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
37357000 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.07
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
204891
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
144690
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.01
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1088612
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28084000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12814000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15270000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28060000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12139000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15921000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
227000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
318000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
663000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
969000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
424000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
552000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1425693
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12500
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M14D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2898000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1009489
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.20
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y4M13D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2598000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
703529
CY2023Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y4M9D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1402000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
979000 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1041000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
116000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.281 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.591 pure
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
252000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
216000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
732000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
674000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
28000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
22000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
85000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
69000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
280000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
238000 usd
us-gaap Lease Cost
LeaseCost
817000 usd
us-gaap Lease Cost
LeaseCost
743000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
762000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
676000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
310000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
258000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
642000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
306000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
241000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
217000 usd
CY2023Q3 ulbi Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
426000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2090000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
210000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
323000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
133000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
260000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
247000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
98000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
94000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
485000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
286000 usd
CY2023Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1121000 usd
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
682000 usd
CY2023Q3 us-gaap Revenues
Revenues
39488000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2135000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-386000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1330000 usd
CY2022Q3 us-gaap Revenues
Revenues
33234000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-586000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
254000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-239000 usd
us-gaap Revenues
Revenues
114096000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5826000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
178000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1688000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8000 usd
us-gaap Net Income Loss
NetIncomeLoss
4324000 usd
us-gaap Revenues
Revenues
95733000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-88000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-171000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-0 usd
us-gaap Net Income Loss
NetIncomeLoss
105000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39488000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
95733000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39488000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
33234000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
114096000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
95733000 usd

Files In Submission

Name View Source Status
0001437749-23-029036-index-headers.html Edgar Link pending
0001437749-23-029036-index.html Edgar Link pending
0001437749-23-029036.txt Edgar Link pending
0001437749-23-029036-xbrl.zip Edgar Link pending
ex_583568.htm Edgar Link pending
ex_583569.htm Edgar Link pending
ex_583570.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20230930.xsd Edgar Link pending
ulbi20230930_10q.htm Edgar Link pending
ulbi-20230930_cal.xml Edgar Link unprocessable
ulbi-20230930_def.xml Edgar Link unprocessable
ulbi-20230930_lab.xml Edgar Link unprocessable
ulbi-20230930_pre.xml Edgar Link unprocessable
ulbi20230930_10q_htm.xml Edgar Link completed